Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Share-based Compensation (2016 - 2026)

Healthequity has reported Share-based Compensation over the past 14 years, most recently at $19.1 million for Q1 2026.

  • For Q1 2026, Share-based Compensation fell 11.94% year-over-year to $19.1 million; the TTM value through Jan 2026 reached $73.1 million, down 24.23%, while the annual FY2026 figure was $73.1 million, 24.23% down from the prior year.
  • Share-based Compensation for Q1 2026 was $19.1 million at Healthequity, down from $20.5 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $32.0 million in Q2 2024 and troughed at $11.0 million in Q1 2022.
  • A 5-year average of $18.8 million and a median of $19.1 million in 2025 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: skyrocketed 75.9% in 2024 and later plummeted 55.23% in 2025.
  • Year by year, Share-based Compensation stood at $18.2 million in 2022, then rose by 19.22% to $21.7 million in 2023, then decreased by 2.49% to $21.1 million in 2024, then decreased by 2.75% to $20.5 million in 2025, then decreased by 6.94% to $19.1 million in 2026.
  • Business Quant data shows Share-based Compensation for HQY at $19.1 million in Q1 2026, $20.5 million in Q4 2025, and $19.1 million in Q3 2025.